Deep Track Capital, LP Hille Vax, Inc. Transaction History

Deep Track Capital, LP

  • $2.71 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.86 - $15.93 $8.77 Million - $11.8 Million
-739,808 Reduced 28.76%
1,832,652 $26.5 Million
Q1 2024

May 15, 2024
SELL
$14.15 - $19.75 $4.63 Million - $6.47 Million
-327,540 Reduced 11.29%
2,572,460 $42.8 Million
Q3 2023

Nov 14, 2023
BUY
$11.59 - $16.7 $33.6 Million - $48.4 Million
2,900,000 New
2,900,000 $39 Million

Others Institutions Holding HLVX

# of Institutions
80
Shares Held
36.8M
Call Options Held
0
Put Options Held
0
View Full List

About HilleVax, Inc.

HLVX Quotes by TradingView
  • Ticker HLVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,427,200
  • Market Cap $63.5M
  • Description
  • HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.
More about HLVX
Track This Portfolio

Track Deep Track Capital, LP Portfolio

Follow Deep Track Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Deep Track Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email